Hypoxia, radiotherapy, hypofractionation, BCON, BC2001, chemotherapy, transcriptomics
Sri Lanka, breast cancer, cost-effectiveness analysis, adjuvant therapy, health technology assessment, LMIC
lung cancer, adjuvant treatment, neoadjuvant treatment, novel cancer therapeutics, immunotherapy, health economics, cost-effectiveness analysis, low and middle income countries, Markov modelling